Stay updated with breaking news from Guide Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mana.bio's first-of-its-kind AI platform discovers and optimizes novel, customizable LNPs for tissue-specific delivery of nucleic acid-based therapeutics and vaccinesLed by a multidisciplinary team with expertise in drug delivery, nanotechnology, and
/PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery...
CRISPR startups and large pharmaceutical companies are combining their respective strengths to accelerate the development of CRISPR treatments
Gene-editing medicines developer Intellia Therapeutics is paying $45 million up front to acquire Rewrite Therapeutics. The startup’s technology brings Intellia another tool for its genetic medicines toolbox, one that could enable even more precise edits.